Gene Review:
FOP - Fibrodysplasia ossificans progressiva
Homo sapiens
This record was replaced with 90.
- Mast cell involvement in fibrodysplasia ossificans progressiva. Gannon, F.H., Glaser, D., Caron, R., Thompson, L.D., Shore, E.M., Kaplan, F.S. Hum. Pathol. (2001)
- Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. Ahn, J., Serrano de la Pena, L., Shore, E.M., Kaplan, F.S. The Journal of bone and joint surgery. American volume. (2003)
- A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family. Fontaine, K., Sémonin, O., Legarde, J.P., Lenoir, G., Lucotte, G. Genetic counseling (Geneva, Switzerland) (2005)
- Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Schaffer, A.A., Kaplan, F.S., Tracy, M.R., O'Brien, M.L., Dormans, J.P., Shore, E.M., Harland, R.M., Kusumi, K. Spine. (2005)
- The human bone morphogenetic protein 4 (BMP-4) gene: molecular structure and transcriptional regulation. Shore, E.M., Xu, M., Shah, P.B., Janoff, H.B., Hahn, G.V., Deardorff, M.A., Sovinsky, L., Spinner, N.B., Zasloff, M.A., Wozney, J.M., Kaplan, F.S. Calcif. Tissue Int. (1998)
- Corrigendum: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Brown, M.A., Kaplan, F.S. Nat. Genet. (2007)
- Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. Shafritz, A.B., Shore, E.M., Gannon, F.H., Zasloff, M.A., Taub, R., Muenke, M., Kaplan, F.S. N. Engl. J. Med. (1996)
- Fibrodysplasia ossificans progressiva (myositis ossificans progressiva) treatment with disodium etidronate. Hall, J.G., Schaller, J.G., Worsham, N.G., Horning, M.R., Staheli, L.T. J. Pediatr. (1979)
- Treatment of patients who have fibrodysplasia ossificans progressiva with isotretinoin. Zasloff, M.A., Rocke, D.M., Crofford, L.J., Hahn, G.V., Kaplan, F.S. Clin. Orthop. Relat. Res. (1998)
- Technetium-99m MDP demonstration of heterotopic ossification in fibrodysplasia ossificans progressiva. Fang, M.A., Reinig, J.W., Hill, S.C., Marini, J., Zasloff, M.A. Clinical nuclear medicine. (1986)
- Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progressiva (FOP). Xu, M.Q., Feldman, G., Le Merrer, M., Shugart, Y.Y., Glaser, D.L., Urtizberea, J.A., Fardeau, M., Connor, J.M., Triffitt, J., Smith, R., Shore, E.M., Kaplan, F.S. Clin. Genet. (2000)
- Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. de la Peña, L.S., Billings, P.C., Fiori, J.L., Ahn, J., Kaplan, F.S., Shore, E.M. J. Bone Miner. Res. (2005)
- Consideration of Rituximab for fibrodysplasia ossificans progressiva. Altschuler, E.L. Med. Hypotheses (2004)
- Activation of the canonical beta-catenin pathway by histamine. Diks, S.H., Hardwick, J.C., Diab, R.M., van Santen, M.M., Versteeg, H.H., van Deventer, S.J., Richel, D.J., Peppelenbosch, M.P. J. Biol. Chem. (2003)
- Studies on alkaline phosphatase activity cultured cells from a patient with fibrodysplasia ossificans progressiva. Miller, R.L., Maxwell, W.A., Spicer, S.S., Halushka, P.V., Varner, H.H., Westphal, M.C. Lab. Invest. (1977)
- (n-3) fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. Tinker, L.F., Parks, E.J., Behr, S.R., Schneeman, B.O., Davis, P.A. J. Nutr. (1999)
- Fibrodysplasia ossificans progressiva. Biochemical changes in blood serum, urine, skin, bone, and ectopic ossification. Blumenkrantz, N., Asboe-Hansen, G. Scand. J. Rheumatol. (1978)
- Fibrodysplasia ossificans progressiva: current concepts and the role of CT in acute changes. Lindhout, D., Golding, R.P., Taets van Amerongen, A.H. Pediatric radiology. (1985)
- Initiation of fracture repair by bone morphogenetic proteins. Reddi, A.H. Clin. Orthop. Relat. Res. (1998)
- Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). Fiori, J.L., Billings, P.C., de la Peña, L.S., Kaplan, F.S., Shore, E.M. J. Bone Miner. Res. (2006)
- Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22. Lucotte, G., Bathelier, C., Mercier, G., Gérard, N., Lenoir, G., Sémonin, O., Fontaine, K. Genetic counseling (Geneva, Switzerland) (2000)
- Fibrodysplasia (myositis) ossificans progressiva. Bridges, A.J., Hsu, K.C., Singh, A., Churchill, R., Miles, J. Semin. Arthritis Rheum. (1994)
- Anaesthetic management of a child with fibrodysplasia ossificans progressiva. Tumolo, M., Moscatelli, A., Silvestri, G. British journal of anaesthesia. (2006)
- Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Kitterman, J.A., Kantanie, S., Rocke, D.M., Kaplan, F.S. Pediatrics (2005)
- Anesthetic management in fibrodysplasia ossificans progressiva (FOP): a case report. Singh, A., Ayyalapu, A., Keochekian, A. Journal of clinical anesthesia. (2003)